Alcide Corporation

Other

Hydro Optics, Inc.

Kantian Sciences Corporation

Profresh Properties Inc.

Kantian Skincare LLC

Lori Fox Reid

Robert D Kross

G Kere Kemp

Elliott Justin Siff

Eugene A Davidson

Carol A Zamojcin

David I Scheer

William Wade

Cleva Villanueva

Robert Lofaro

Nicholas D Mulder

Guadalupe Cleva Villanueva Lopez

A treatment for a hyperglycemic condition, including diabetes mellitus, includes the step of administering to a human being dimethylformamide ('DMF'), which has the chemical structural formula: DMF can be administered to the human patient in a wide variety of ways, however it is preferable that the administration of DMF be performed orally and the dose of DMF could be combined with numerous inert substances known to the prior art, such as a sugarless fruit juice concentrate. The preferred daily dosage of DMF administered to a person would be about 0.041 mg/kg body weight to about 1.23 mg/kg of body weight of the person.

Reduction of hyperglycemia by administration of dimethylformamide for treating hyperglycemic conditions, including diabetes mellitus

A two-part aqueous composition for treating skin ailments, such as acne vulgaris, includes an acidic part having salicylic acid and an &#x3b1;-hydroxy acid, and an alkaline part having an alkaline nitrite salt. The &#x3b1;-hydroxy acid is preferably glycolic acid, lactic acid, malic acid, mandelic acid or a combination thereof. The alkaline nitrite salt is preferably sodium nitrite. The acidic part and the alkaline part are an acidic aqueous solution and an alkaline aqueous solution, respectively, which may either be mixed with one another then applied to an affected portion of a patient's skin or, alternatively, may be sequentially applied to the affected portion of the patient's skin, preferably within 15 minutes of one another.

Multifunctional topical formulation for the treatment of acne vulgaris and other skin conditions

An antimicrobial oxychlorine oral rinse composition for preventing and treating oral malodor and diseases, tooth decay with improved palatability and tissue compatibility, includes an aqueous chlorine dioxide and chlorite ion solution with the chlorite ion predominating in the multiple oxychlorine rinse composition. A method for preparing such antimicrobial oxychlorine oral rinse composition comprising 3 ppm to about 200 ppm of chlorine dioxide, by first preparing an aqueous solution with about 7 to 400 ppm of chlorite ion; then an aqueous acidifying agent concentrate which, upon introduction to the chlorite solution, reduces its pH to about 4.5 to 6.0; then a second aqueous buffer-producing oxidant combination concentrate. The first acidifying agent concentrate is added to the chlorite ion solution and the second aqueous buffer-producing oxidant combination concentrate is added to the acidified chlorite ion solution, producing an antimicrobial oxychlorine oral rinse composition at about 5.0 to 6.8 pH.

Oxychlorine oral rinse composition having enhanced oral-tissue compatibility for the destruction of malodorants, their putrefactive microbial sources and gum-disease pathogens and a method for the preparation thereof

A composition article, which may be applied to human, includes a non-oil thermoplastic gelatinous elastomer composition, which is formed into a composite by heating with a substrate material. The gelatinous elastomer includes a hydrogenated styrene/isoprene/butadiene block copolymer, at least one polymer or copolymer of the group poly(styrene-butadiene-styrene), poly(styrene-isoprene), poly(styrene-isoprene-styrene), poly(styrene-isoprene), poly(styrene-ethylene-propylene), poly(styrene-ethylene-propylene-styrene), poly(styrene-ethylene-butylene-styrene) or poly(styrene-ethylene-butylene), and a non-oil plasticizer.

Oil-free viscoelastic elastomer gels for application to human skin

A composition and method are described for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition. Fibrous adhesions typically form during healing of tissue, for example following a surgical procedure. A multicomponent oxychlorine composition is provided for irrigating the tissue which minimizes post-surgical adhesion formation, the composition containing both chlorine dioxide and chlorite ion, and a complexion thereof. The chlorine dioxide level generally is in an effective range of ClOconcentration from about 10 ppm to a maximum of about 110 ppm. In a preferred embodiment, a physiological composition is provided in a thickened form to increase retention in the area being treated. The composition is preferably based on a standard saline solution converted to the oxychlorine composition just prior to use by sequential addition of aqueous concentrates of a chlorite salt, a hypochlorite salt combined with a physiological buffer-producing salt of a multibasic acid, and an acidifying agent, optionally including a thickening agent.

Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site

This invention relates generally to compositions and methods useful for oral hygiene rinses, and more specifically to oral rinses in which the antimicrobial activity of chlorous acid is supplemented by that of lactic acid as one of a combination of antimicrobial acids, preferably acids which serve to partially convert chlorite ion to chlorous acid.

Disinfecting oral rinse compositions and process for using the same

A method for transiently and controllably enhancing the adhesion of a hydrogel composition to select substrates for facilitating the handling of the hydrogel composition during processing, includes the steps of placing the hydrogel composition in a liquid state onto a plastic film facestock, which has biaxially-oriented polypropylene, microporous cellulose acetate or a combination thereof, for temporarily adhering the hydrogel composition to the sheets of the roll stock during processing of the hydrogel composition, and then removing the hydrogel composition from the sheets of the roll stock, after processing of the hydrogel composition is complete, without any adverse affect on the textural qualities of the hydrogel composition.

Method for controlling a hydrogel composition during processing

Method for using glycol additives to texturally modify natural gum hydrogels

The present invention is directed to disinfecting compositions for dental unit water lines, particularly effective against microbial flora in biofilms which form on the luminal walls of the piping and reservoir components of dental equipment, as well as methods related to the use of such compositions to reduce microbial numbers in water-bearing dental and other equipment and maintain reduced levels on a continuous basis.

Methods for disinfecting small diameter water lines

A frozen chlorine dioxide-containing composition comprising a metal chlorite and a protic acid in a frozen aqueous matrix made by freezing a substantially chloride dioxide-free aqueous solution comprising a metal chlorite at a concentration ranging from about 0.0005% to about 0.5% by weight and a protic acid at a concentration sufficient to lower the pH of the aqueous solution to a value of about 1.8 to about 5.0. The frozen chlorine dioxide-containing composition has a chlorine dioxide concentration of more than about 3 ppm, while the aqueous solution prior to freezing has a chlorine dioxide concentration less than about 3 ppm. The frozen chlorine dioxide-containing composition is used to disinfect substrates by contacting the same with the frozen chlorine dioxide-containing composition. Suitable substrates include food intended for human or animal consumption, such as meat, fish and poultry.

Frozen chlorine dioxide-containing composition and methods related thereto

The present invention is directed to both physical and chemical means for maintaining continuous high levels of chlorine dioxide in aqueous solutions for extended periods, with minimum loss through degradation in the solution and dissipation through the walls of the containing vessel within which the solution is stored. The ClO,may be maintained even in the absence of very high levels of chlorite, from which supplemental, offsetting levels of ClO,may be generated. The present invention relates to the discovery that certain types of plastic and glass containers have the ability to maintain relatively constant levels of ClO,in their contained solutions over extended periods, particularly in aqueous compositions comprising chlorite/ClO,ratios sufficient for a stabilizing complex of the two, presumably Cl,0,, to suppress the ClO,loss. Of particular value is certain high-density polyethylene terephthalate (PETE) plastic bottling and plastic containers which have been initially exposed to a fluorinating environment. Specifically, in the latter regard, it has been discovered that certain plastic containers which ordinarily are incapable of maintaining aqueous ClO,levels can be treated with fluorine gas to transform their surfaces so as to effectively suppress ClO,diffusion therethrough.

Compositions and methods for storing aqueous chlorine dioxide solutions

There is disclosed a method for treating dermatologic diseases caused by microbial overgrowth or inflammation, such as psoriasis, fungal infections, eczema, dandruff, acne, genital herpes lesions, and leg ulcers. There is further disclosed an antiviral lubricating composition that is effective in preventing the transmission of the HIV virus and other sexually transmitted diseases. There is also disclosed systemic and anti-inflammatory compositions and formulations and a method for reducing tissue inflammation in tissues such as the bowel, muscle, bone, tendon and joints (e.g., arthritis).

Anti-inflammatory formulations for inflammatory diseases

An animal feed composition for reducing colonization of animal intestines by Salmonella and other bacterial pathogens, includes a polysaccharide containing cis-hydroxy sugar units or a derivative thereof, or the monosaccharide ribose or rhamnose, or a derivative thereof, and an animal feed. The polysaccharide cis-hydroxy sugar units may be one or more of mannose, a mannose derivative, galactose, a galactose derivative, galactomannans, galactosamine, fucose and arabinose. The polysaccharides may be incorporated into an animal feed in the form of a food gum or other biolpolymer.

Growing community of inventors

Bellmore, NY, United States of America

Robert D Kross